Tuberculosis Flashcards

1
Q

What is tuberculosis (TB)?

A

Tuberculosis is a disease caused by Mycobacterium tuberculosis, primarily affecting the lungs but can affect other organs. It is the leading cause of death from a single infectious agent, surpassing HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is TB transmitted?

A

TB is spread through airborne droplets containing Mycobacterium tuberculosis. Inhalation of these droplets can lead to infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the symptoms of TB?

A

Symptoms include weight loss, loss of appetite, night sweats, fever, fatigue, chills, coughing, and chest pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the types of TB?

A

Drug-sensitive TB, multidrug-resistant TB (MDR-TB), and extensively drug-resistant TB (XDR-TB).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What makes Mycobacterium tuberculosis unique?

A

It has a lipid-rich cell wall with mycolic acid, making it waxy and resistant to digestion. It grows slowly, dividing every 15-20 hours, and has intrinsic resistance to most antibiotics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the primary aims of TB treatment?

A

To cure the patient, minimize risk of death and disability, prevent relapse, decrease transmission, and prevent acquired resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the first-line treatment for drug-sensitive TB?

A

A combination of isoniazid, rifampicin, ethambutol, or streptomycin, and pyrazinamide, taken daily for at least 6 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does isoniazid work?

A

Isoniazid inhibits the synthesis of mycolic acid, a critical component of the mycobacterial cell wall. It is a pro-drug activated by the catalase-peroxidase enzyme KatG and is bactericidal against actively dividing bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What causes resistance to isoniazid?

A

Resistance is primarily due to mutations in the KatG gene, which prevents activation of the pro-drug. Mutations in InhA can also reduce binding of the drug to its target.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the adverse effects of isoniazid?

A

Adverse effects include hepatitis, particularly in older individuals and alcoholics, due to toxic metabolites formed by CYP450 enzymes. Nerve damage can also occur due to pyridoxine depletion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does rifampicin work?

A

Rifampicin inhibits DNA-dependent RNA polymerase, preventing RNA synthesis. It is well-distributed in tissues, body fluids, and cerebrospinal fluid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of pyrazinamide?

A

Pyrazinamide is a pro-drug activated in acidic conditions. It disrupts membrane potential and energy production in Mycobacterium tuberculosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What causes resistance to pyrazinamide?

A

Resistance arises from impaired uptake or mutations in the pyrazinamidase enzyme (pncA), which prevents activation of the pro-drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does ethambutol work?

A

Ethambutol inhibits the enzyme arabinosyl transferase, disrupting arabinogalactan synthesis, which leads to increased cell wall permeability. It is bacteriostatic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is MDR-TB?

A

Multidrug-resistant TB is caused by strains of M. tuberculosis resistant to at least both isoniazid and rifampicin, requiring prolonged and complex treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is XDR-TB?

A

Extensively drug-resistant TB is resistant to isoniazid, rifampin, any fluoroquinolone, and at least one Group 2 parenteral second-line agent, such as aminoglycosides. It has high mortality rates.

17
Q

What is bedaquiline and how does it work?

A

Bedaquiline is a novel anti-TB agent that inhibits mycobacterial ATP synthetase, making it effective against resistant isolates. It is used for MDR-TB.

18
Q

Why was bedaquiline approved despite risks?

A

It was approved due to the high risk of fatal outcomes and the spread of resistance associated with inadequate TB treatment. The benefit-risk balance justified its use.

19
Q

What are the challenges in TB treatment?

A

Challenges include slow development of new drugs, lack of rapid diagnostics, poor treatment compliance, and ongoing resistance. Vaccine trials are underway.